UPDATED Jun 14, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
POLYDM | RM0.75 | 0% | n/a | RM66.2m | n/a | PE9.6x | n/a | 1.3% | Capital Goods | ||
HAKK.P | CA$0.075 | 0% | n/a | CA$698.2k | n/a | PE53x | n/a | n/a | Diversified Financials | ||
UMW | RM4.97 | 1.0% | 32.5% | RM5.8b | RM5.09 | PE8.1x | E-13.3% | 2.9% | Automobiles | ||
BJP | د.أ2.80 | 0% | n/a | د.أ19.6m | n/a | PE9.8x | n/a | 3.6% | Pharmaceuticals & Biotech | ||
QRT | UK£1.40 | 7.7% | 16.7% | UK£57.2m | n/a | PE5.3x | n/a | 0% | Media | ||
FIVD.P | CA$0.10 | 0% | n/a | CA$372.9k | n/a | PB1.9x | n/a | n/a | Diversified Financials | ||
AEL | PK₨33.68 | 0% | 95.8% | PK₨269.4m | n/a | PE55.6x | n/a | n/a | Utilities | ||
ROL | €0.019 | 0% | n/a | €1.1m | n/a | PB0.3x | n/a | n/a | Household | ||
A085370 | ₩36,700.00 | 0% | 85.8% | ₩949.5b | ₩34,500.00 | PE33.1x | E26.4% | 0.9% | Healthcare | ||
1400 | JP¥100.00 | 0% | -2.0% | JP¥1.3b | n/a | PE12.5x | n/a | n/a | Capital Goods | ||
SLIC | RM0.69 | 0% | n/a | RM87.0m | n/a | PE21.2x | n/a | 4.4% | Software | ||
PMIN | US$1.00 | 0% | n/a | US$15.5m | n/a | PB249.9x | n/a | n/a | Food, Beverage & Tobacco | ||
MCI | UK£0.04 | 0% | n/a | UK£885.3k | n/a | PB1.5x | n/a | n/a | Diversified Financials | ||
SLE | UK£0.17 | 0% | -58.8% | UK£74.2m | n/a | PE3.8x | E-74.1% | n/a | Energy | ||
SCPL | US$22.94 | 0.04% | 68.7% | US$2.9b | US$22.96 | PE20.9x | E8.7% | n/a | Media | ||
2599 | NT$15.20 | 0% | 1.0% | NT$1.5b | n/a | PE26.9x | n/a | 9.9% | Real Estate Management and Development | ||
FIBPRIME | US$6.64 | -0.2% | n/a | US$23.4m | n/a | PE191.1x | n/a | n/a | Diversified Financials | ||
TALS | US$27.20 | -4.9% | 91.5% | US$553.2m | US$200.00 | PB3.7x | n/a | n/a | Pharmaceuticals & Biotech | ||
CODE | CA$0.11 | 0% | -66.2% | CA$1.7m | n/a | PS103.5x | n/a | n/a | Software | ||
KDNY | US$40.39 | 0.3% | 95.7% | US$2.9b | US$40.09 | PS495.8x | E22.6% | n/a | Pharmaceuticals & Biotech | ||
AKUM | лв160.00 | 0% | n/a | лв1.2m | n/a | PE1.3x | n/a | n/a | Materials | ||
SELI.N0000 | LK₨808.50 | 0% | 45.0% | LK₨4.6b | n/a | PE333x | n/a | 0% | Diversified Financials | ||
8249 | JP¥1,693.00 | 0% | 46.6% | JP¥31.6b | n/a | PE13.4x | n/a | 2.2% | Capital Goods | ||
CTO | CA$2.08 | -0.5% | 48.6% | CA$21.3m | n/a | PE21.4x | n/a | 2.9% | Capital Goods |